Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value

References

• Li Y, Wang X, Chen S, et al. Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma. Mol Biol Rep. 2022;2022:1–10.
   Google Scholar
• Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014:1–18. doi:10.1155/2014/437971
   Google Scholar
• Gharib AF, Eed EM, Khalifa AS, et al. Value of serum miRNA-96-5p and miRNA-99a-5p as diagnostic biomarkers for hepatocellular carcinoma. Int J Gen Med. 2022;15(null):2427–2436. doi:10.2147/IJGM.S354842
   PubMedGoogle Scholar
• Zhang H, Chen X, Yuan Y. Investigation of the miRNA and mRNA coexpression network and their prognostic value in hepatocellular carcinoma. Biomed Res Int. 2020;2020. doi:10.1155/2020/8726567
   Web of Science ®Google Scholar
• Wang T, Zhang K-H. New blood biomarkers for the diagnosis of AFP-negative hepatocellular carcinoma. Front Oncol. 2020;10:1316. doi:10.3389/fonc.2020.01316
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng Y, Xiao X, et al. A circulating long noncoding RNA panel serves as a diagnostic marker for hepatocellular carcinoma. Dis Markers. 2020;2020:5417598. doi:10.1155/2020/5417598
   PubMed Web of Science ®Google Scholar
• Shehab-Eldeen S, Metwaly MF, Saber SM, El-Kousy SM, Badr EAE, Essa A. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular Carcinoma. Digest Liver Dis. 2022;55:283–290. doi:10.1016/j.dld.2022.04.015
   Web of Science ®Google Scholar
• Yang W-J, Sun Y-F, Jin A-L, et al. BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity. Cell Death Dis. 2020;11(10):1–13. doi:10.1038/s41419-020-03115-3
   PubMed Web of Science ®Google Scholar
• Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non‐coding RNA‐associated competitive endogenous RNA regulatory networks: novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med. 2022;26(2):287–305. doi:10.1111/jcmm.17126
   PubMed Web of Science ®Google Scholar
• Tang G, Luo L, Zhang J, et al. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma. Cancer Lett. 2021;498:152–164. doi:10.1016/j.canlet.2020.10.047
   PubMed Web of Science ®Google Scholar
• Zhou R, Sun H, Zheng S, et al. A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer. J Cell Mol Med. 2020;24(5):3229–3241.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang -D-D, Liu J-B, et al. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Mol Ther Nucleic Acids. 2021;23:702–718. doi:10.1016/j.omtn.2020.12.016
   PubMedGoogle Scholar
• Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L. LINC 00152: a pivotal oncogenic long non‐coding RNA in human cancers. Cell Prolif. 2017;50(4):e12349. doi:10.1111/cpr.12349
   PubMed Web of Science ®Google Scholar
• Matis S, Rossi M, Brondolo L, et al. LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells. Hematol Oncol. 2022;40(1):41–48. doi:10.1002/hon.2938
   Web of Science ®Google Scholar
• Bian Z, Zhang J, Li M, et al. Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis. 2017;6(11):1–11. doi:10.1038/s41389-017-0008-4
   Google Scholar
• Ramli S, Sim MS, Guad RM, et al. Long noncoding RNA UCA1 in gastrointestinal cancers: molecular regulatory roles and patterns, mechanisms, and interactions. J Oncol. 2021;2021. doi:10.1155/2021/5519720
   PubMed Web of Science ®Google Scholar
• An M, Xing X, Chen T. Long non‑coding RNA UCA1 enhances cervical cancer cell proliferation and invasion by regulating microRNA‑299‑3p expression. Oncol Lett. 2021;22(5):1–9. doi:10.3892/ol.2021.13033
   Web of Science ®Google Scholar
• Qin LT, Tang RX, Lin P, et al. Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: investigation with in vitro and meta-analysis. Pathol Res Pract. 2018;214(9):1260–1272. doi:10.1016/j.prp.2018.03.025
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Bergmeyer H, Horder M, Rey J. Approved recommendation on IFCC methods for the measurement of catalytic enzymes. Part 3: IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem. 1986;24:481–495.
   PubMedGoogle Scholar
• Doumas BT, Perry BW, Sasse EA, Straumfjord JV Jr. Standardization in bilirubin assays: evaluation of selected methods and stability of bilirubin solutions. Clin Chem. 1973;19(9):984–993. doi:10.1093/clinchem/19.9.984
   PubMed Web of Science ®Google Scholar
• Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem. 1978;24(1):80–86. doi:10.1093/clinchem/24.1.80
   PubMed Web of Science ®Google Scholar
• Gitlin D. Normal biology of α‐fetoprotein. Ann N Y Acad Sci. 1975;259(1):7–16. doi:10.1111/j.1749-6632.1975.tb25397.x
   PubMedGoogle Scholar
• Colman RW. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott Williams & Wilkins; 2006.
   Google Scholar
• Dorak MT. Real-Time PCR. Taylor & Francis; 2007.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Zhao J, Greene CM, Gray SG, Lawless MW. Long noncoding RNAs in liver cancer: what we know in 2014. Expert Opin Ther Targets. 2014;18(10):1207–1218. doi:10.1517/14728222.2014.941285
   PubMed Web of Science ®Google Scholar
• Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.3055
   PubMed Web of Science ®Google Scholar
• Seo SI, Kim SS, Choi BY, et al. Clinical significance of elevated serum alpha-fetoprotein (AFP) level in acute viral hepatitis A (AHA). Hepato-Gastroenterology. 2013;60(127):1592–1596.
   PubMedGoogle Scholar
• Wong CR, Garcia RT, Trinh HN, et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci. 2009;54(12):2712–2721. doi:10.1007/s10620-009-1015-x
   PubMed Web of Science ®Google Scholar
• Li H, Li Y, Liu D, Sun H, Liu J. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells. Cell Physiol Biochem. 2013;32(2):448–458. doi:10.1159/000354450
   PubMedGoogle Scholar
• Zhang Z, Li J, Wei Z, et al. Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer. Eur Rev Med Pharmacol Sci. 2020;24(7):3586–3591. doi:10.26355/eurrev_202004_20820
   PubMed Web of Science ®Google Scholar
• Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol. 2006;12(8):1175. doi:10.3748/wjg.v12.i8.1175
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhou J-K, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77. doi:10.1186/s12943-020-01188-4
   PubMed Web of Science ®Google Scholar
• Li H, Yu B, Li J, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5(8):2318. doi:10.18632/oncotarget.1913
   PubMedGoogle Scholar
• Beylerli O, Gareev I, Sufianov A, Ilyasova T, Guang Y. Long noncoding RNAs as promising biomarkers in cancer. Noncoding RNA Res. 2022;7(2):66–70. doi:10.1016/j.ncrna.2022.02.004
   PubMed Web of Science ®Google Scholar
• DiStefano JK. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. Non-Coding RNA Res. 2017;2(3–4):129–136. doi:10.1016/j.ncrna.2017.11.001
   PubMedGoogle Scholar
• Li J, Wang X, Tang J, et al. HULC and Linc00152 Act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cell Physiol Biochem. 2015;37(2):687–696. doi:10.1159/000430387
   PubMed Web of Science ®Google Scholar
• Abdelrahman E, El-Aal A, Sobhy M, Shamsya A, Zanet Y, Bedewy EE. Serum long intergenic non-coding ribonucleic acid LINC00152 as a potential predictor of hepatocellular carcinoma in Egyptian patients. Afro-Egypt J Infect Enem Dis. 2020;10(3):264–270. doi:10.21608/aeji.2020.29616.1078
   Google Scholar
• Wang B, Yang S, Zhao W. Long non-coding RNA NRAD1 and LINC00152 are highly expressed and associated with prognosis in patients with hepatocellular carcinoma. Onco Targets Ther. 2020;13:10409–10416. doi:10.2147/ott.S251231
   PubMed Web of Science ®Google Scholar
• Deng X, Zhao X, Liang X, Chen R, Pan Y, Liang J. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Biomed Pharmacother. 2017;90:100–108. doi:10.1016/j.biopha.2017.03.031
   PubMed Web of Science ®Google Scholar
• Tian Q, Yan X, Yang L, Liu Z, Yuan Z, Zhang Y. lncRNA CYTOR promotes cell proliferation and tumor growth via miR‑125b/SEMA4C axis in hepatocellular carcinoma. Oncol Lett. 2021;22(5):1–12. doi:10.3892/ol.2021.13057
   Web of Science ®Google Scholar
• Ji J, Tang J, Deng L, et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget. 2015;6(40):42813. doi:10.18632/oncotarget.5970
   PubMedGoogle Scholar
• Hu B, Yang X-B, Yang X, Sang X-T. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis. Aging. 2021;13(2):2626. doi:10.18632/aging.202306
   Google Scholar
• Wang J, Zhang Y, Lu L, Lu Y, Tang Q, Pu J. Insight into the molecular mechanism of LINC00152/miR‐215/CDK13 axis in hepatocellular carcinoma progression. J Cell Biochem. 2019;120(11):18816–18825. doi:10.1002/jcb.29197
   PubMed Web of Science ®Google Scholar
• Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582(13):1919–1927. doi:10.1016/j.febslet.2008.05.012
   PubMed Web of Science ®Google Scholar
• Duan W, Du L, Jiang X, et al. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 2016;7(48):78850. doi:10.18632/oncotarget.12880
   PubMedGoogle Scholar
• Pan J, Xie X, Li H, Li Z, Ren C, Ming L. Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence. Int J Clin Exp Pathol. 2019;12(8):2951.
   PubMed Web of Science ®Google Scholar
• Wang J, Gao Y, Wang X, et al. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis based on 15 published articles. Int J Biol Markers. 2020;35(2):40–48. doi:10.1177/1724600820926685
   PubMed Web of Science ®Google Scholar
• Wang W, Yin Z. Diagnostic value of long non-coding RNA H19, UCA1, and HOTAIR as promising biomarkers in human bladder cancer. Int J Clin Exp Pathol. 2017;10(12):11659.
   PubMed Web of Science ®Google Scholar
• Li J, Gao J, Kan A, Hao T, Huang L. SNHG and UCA1 as prognostic molecular biomarkers in hepatocellular carcinoma: recent research and meta-analysis. Minerva Med. 2017;108(6):568–574. doi:10.23736/S0026-4806.17.05094-7
   PubMed Web of Science ®Google Scholar
• Wang F, Ying H-Q, B-S H, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015;6(10):7899. doi:10.18632/oncotarget.3219
   PubMed Web of Science ®Google Scholar
• El-Tawdi AH, Matboli M, El-Nakeep S, Azazy AE, Abdel-Rahman O. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2016;10(7):869–877. doi:10.1080/17474124.2016.1193003
   PubMed Web of Science ®Google Scholar
• Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J, Liu WC. Serum long noncoding RNA urothelial carcinoma-associated 1: a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Inter Med Res. 2018;46(1):348–356. doi:10.1177/0300060517726441
   PubMed Web of Science ®Google Scholar
• Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AH. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Translat Res. 2016;168:134–145. doi:10.1016/j.trsl.2015.10.002
   PubMed Web of Science ®Google Scholar